Log in or Sign up for Free to view tailored content for your specialty!
Spondyloarthropathies News
Higher secukinumab dose yields no clinical difference after inadequate response in AS
Increasing the dosage of secukinumab failed to improve ankylosing spondylitis outcomes among patients who initially demonstrated an inadequate treatment response, according to data published in Rheumatology.
Minimally invasive procedures can reduce osteoarthritis, sacroiliac pain
Radiofrequency ablation and transcatheter arterial embolization — both minimally invasive procedures — can improve pain and function in patients with osteoarthritis or chronic sacroiliac pain of degenerative origin, according to data.
Infliximab biosimilar uptake rapidly increased only after release of a third option
Infliximab biosimilar uptake increased by no more than just 5% annually following the release of its first two biosimilars, but then shot up by 13% to 16% for most patients after a third option emerged, according to data.
Log in or Sign up for Free to view tailored content for your specialty!
Safety checklist compiles clinically important DMARD warnings in one place
Nearly all biologic and targeted synthetic disease-modifying antirheumatic drugs come with infection or malignancy warnings from U.S. or European regulatory agencies, according to a study published in Drug Safety.
EU approves 320 mg Bimzelx, 2 mL devices for multiple inflammatory diseases
The European Commission has granted marketing authorization for two devices that administer Bimzelx for the treatment of multiple inflammatory diseases, UCB announced in a press release.
TNF inhibitors equally safe, effective in young- and late-onset ankylosing spondylitis
TNF inhibitors have similar rates of adverse events and treatment response in ankylosing spondylitis regardless of whether the disease developed early or late in life, according to data published in Scientific Reports.
Knowing ‘fluid’ nature of axial spondyloarthritis critical to preventing serious outcomes
ORLANDO, Fla. — Understanding the nuances of spondyloarthropathy diagnostic criteria can help prevent “debilitating” consequences, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.
Long-term exercise program improves physical function in axial SpA beyond ‘usual care’
A long-term, supervised exercise program for patients with axial spondyloarthritis and severe functional limitations improved functional disability and physical quality of life vs. usual care, according to data published in Rheumatology.
Lab results, symptom tracking top list of key metrics among rheumatology patients
The ability to view laboratory results, track symptoms and sharing them with a provider were rated as the most useful potential app functions by patients with rheumatic and musculoskeletal diseases, according to data.
Patients with rheumatoid arthritis, PsA, AS ‘stuck in a cycle of long-term opioid use’
Patients with rheumatic diseases demonstrate a high reliance on opioids around the time of diagnosis, and significant numbers of patients were not on appropriate treatment in the year afterward, according to data in Clinical Rheumatology.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read